MindMaze Therapeutics and Vibra Healthcare Announce Breakthrough Results in Neurorehabilitation

Study shows technology-enabled, high-intensity therapy significantly enhances functional recovery for stroke patients

Mar. 31, 2026 at 10:08am

Got story updates? Submit your updates here. ›

MindMaze Therapeutics and Vibra Healthcare announced the results of a two-year multi-site quality improvement program demonstrating real-world evidence that the integration of technology-enabled, high-dose therapy into standard inpatient rehabilitation significantly enhances functional recovery for stroke patients. The initiative, implemented across five of Vibra's inpatient medical rehabilitation facilities, successfully delivered supplemental, gamified therapy to 210 patients, leading to superior functional gains, enhanced therapy intensity, high patient engagement, and faster discharge to community rates compared to standard of care.

Why it matters

This study validates the feasibility and scalability of integrating high-dose, high-intensity technology-enabled therapy into inpatient rehabilitation settings, addressing a critical gap in stroke care where staffing constraints and patient fatigue often limit the delivery of the recommended higher doses of therapy for better recovery outcomes.

The details

The program utilized MindMaze's suite of neurotherapeutic systems, including MindMotion Go, Izar, and MindPod, which provide the recommended high-dose, high-intensity, whole-body training that remains engaging for the patient while minimizing the setup burden for therapists. Patients in the interventional cohort demonstrated statistically significantly greater improvements over standard of care in both mobility and self-care, averaged a 60% increase in additional therapy per day, and had higher community discharge rates, representing an opportunity to return patients to their homes more quickly.

  • The initiative was implemented over a two-year period.
  • The results were presented at the American Society of Neurorehabilitation (ASNR) annual conference on March 31, 2026.

The players

MindMaze Therapeutics

A global leader in scalable, precision neurotherapeutics, dedicated to redefining the recovery trajectory for patients around the world.

Vibra Healthcare

A post-acute care provider based in Mechanicsburg, Pennsylvania, focused on the development, acquisition, and operation of freestanding specialty acute care hospitals, inpatient medical rehabilitation hospitals, skilled nursing facilities, and outpatient physical rehabilitation centers.

Brad Hollinger

Chairman and CEO of Vibra Healthcare.

Zach Henderson

CEO of MindMaze Therapeutics.

Got photos? Submit your photos here. ›

What they’re saying

“This initiative proves that high-dose, high-intensity technology-enabled therapy is both feasible and scalable across inpatient rehabilitation settings. By integrating MindMaze's platform, we have increased therapy intensity without adding to the staffing burden, leading to meaningfully greater functional recovery for our patients.”

— Brad Hollinger, Chairman and CEO of Vibra Healthcare

“The success of this partnership with Vibra Healthcare validates our mission to set a new global standard for neurorehabilitation. These RWE results show that the MindMaze Therapeutics platform is not just an add-on, but a vital component in maximizing patient outcomes and ensuring a seamless transition from hospital to home.”

— Zach Henderson, CEO of MindMaze Therapeutics

What’s next

The companies plan to continue expanding the program to additional Vibra Healthcare facilities to further demonstrate the scalability and impact of the technology-enabled, high-intensity therapy approach.

The takeaway

This study highlights the potential for technology-enabled, high-dose rehabilitation to revolutionize stroke care by overcoming the limitations of traditional therapy delivery and enabling more patients to achieve optimal functional recovery and a faster return to their communities.